{"content":"<li class=\"n-box-item date-title\" data-end=\"1356757199\" data-start=\"1356670800\" data-txt=\"Wednesday, December 18, 2019\">Friday, December 28, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"738671\" data-ts=\"1356742885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peregrine Pharmaceuticals (PPHM) dips 6.5% in post-session trading after filing a $75M...</a></h4>Peregrine Pharmaceuticals (PPHM) dips <font color=\"red\">6.5%</font> in post-session trading after filing a $75M <a target=\"_blank\" href=\"http://www.theflyonthewall.com/permalinks/entry.php/BMY;PFE;PPHMid1761075/BMY;PFE;PPHM-On-The-Fly-After-Hours-Movers\">at-the-market secondary</a> sales agreement with MLV &amp; Company.<div class=\"tiny-share-widget\" data-id=\"738671\" data-linked=\"Peregrine Pharmaceuticals (PPHM) dips 6.5% in post-session trading after filing a $75M...\" data-tweet=\"$CDMO - Peregrine Pharmaceuticals (PPHM) dips 6.5% in post-session trading after filing a $75M at-the-market secondary sales agreement with MLV &amp; Company. https://seekingalpha.com/news/738671?source=tweet\" data-url=\"https://seekingalpha.com/news/738671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738571\" data-ts=\"1356734199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTI\" target=\"_blank\">TTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: UVXY +7.84%. TVIX +5.87%. VIIX +5.21%. VIXY +4.85%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/UVXY\" title=\"ProShares Ultra VIX Short-Term Futures ETF\">UVXY</a> <font color=\"green\">+7.84%</font>. <a href=\"https://seekingalpha.com/symbol/TVIX\" title=\"VelocityShares Daily 2x VIX Short-Term ETN\">TVIX</a> <font color=\"green\">+5.87%</font>. <a href=\"https://seekingalpha.com/symbol/VIIX\" title=\"VelocityShares VIX Short-Term ETN\">VIIX</a> <font color=\"green\">+5.21%</font>. <a href=\"https://seekingalpha.com/symbol/VIXY\" title=\"ProShares VIX Short-Term Futures ETF\">VIXY</a> <font color=\"green\">+4.85%</font>. <a href=\"https://seekingalpha.com/symbol/VXX\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"green\">+4.37%</font>.  <br><b>After-hours top losers:</b> <a href=\"https://seekingalpha.com/symbol/ILF\" title=\"iShares Latin America 40 ETF\">ILF</a> <font color=\"red\">-6.47%</font>. <a href=\"https://seekingalpha.com/symbol/XIV\" title=\"VelocityShares Daily Inverse VIX Short-Term ETN\">XIV</a> <font color=\"red\">-6.26%</font>. <a href=\"https://seekingalpha.com/symbol/SVXY\" title=\"ProShares Short VIX Short-Term Futures ETF\">SVXY</a> <font color=\"red\">-5.11%</font>. <a href=\"https://seekingalpha.com/symbol/TTI\" title=\"Tetra Technologies Inc.\">TTI</a> <font color=\"red\">-2.97%</font>. <a href=\"https://seekingalpha.com/symbol/UPRO\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a> <font color=\"red\">-2.41%</font>.<div class=\"tiny-share-widget\" data-id=\"738571\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: UVXY +7.84%. TVIX +5.87%. VIIX +5.21%. VIXY +4.85%....\" data-tweet=\"$TTI $UVXY $TVIX - After-hours top gainers, as of 5:15 p.m.: UVXY +7.84%. TVIX +5.87%. VIIX +5.21%. VIXY +4.85%. VXX +4.37%. After-hours top losers: ILF -6.47%. XIV -6.26%. SVXY -5.11%. TTI -2.97%. UPRO -2.41%. https://seekingalpha.com/news/738571?source=tweet\" data-url=\"https://seekingalpha.com/news/738571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738481\" data-ts=\"1356730339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The FDA approves Bristol-Myers&#39; (NYSE:BMY) anti-clotting drug Eliquis. The drug, which reduces...</a></h4><p>The <a href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htm\" target=\"_blank\">FDA approves</a> Bristol-Myers' (NYSE:<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a>) anti-clotting drug Eliquis. The drug, which reduces the risk of stroke and dangerous blood clots in patients with atrial fibrillation, is manufactured by <a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> and co-marketed by Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>). Shares <font color=\"green\">+1.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"738481\" data-linked=\"The FDA approves Bristol-Myers&#39; (NYSE:BMY) anti-clotting drug Eliquis. The drug, which reduces...\" data-tweet=\"$BMY $BMY $PFE - The FDA approves Bristol-Myers&#39; (NYSE:BMY) anti-clotting drug Eliquis. The drug, which reduces the risk of stroke and dangerous blood clots in patients with atrial fibrillation, is manufactured by BMY and co-marketed by Pfizer (NYSE:PFE... https://seekingalpha.com/news/738481?source=tweet\" data-url=\"https://seekingalpha.com/news/738481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738341\" data-ts=\"1356725103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YONG\" target=\"_blank\">YONG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Yongye International (YONG +14.7%) surge the most in more than two months after the...</a></h4><p>Shares of Yongye International (<a href=\"https://seekingalpha.com/symbol/YONG\" title=\"Yongye International Inc\">YONG</a> <font color=\"green\">+14.7%</font>) surge the most in more than two months after the Chinese fertilizer maker said the country\u2019s state-owned bank offered to <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-12-28/china-s-yongye-jumps-most-in-two-month-on-loans-from-state-bank.html\">provide financing</a> of as much as $232M to support its <a href=\"https://seekingalpha.com/currents/post/585731\" target=\"_blank\">going-private deal</a>.</p><div class=\"tiny-share-widget\" data-id=\"738341\" data-linked=\"Shares of Yongye International (YONG +14.7%) surge the most in more than two months after the...\" data-tweet=\"$YONG - Shares of Yongye International (YONG +14.7%) surge the most in more than two months after the Chinese fertilizer maker said the country\u2019s state-owned bank offered to provide financing of as much as $232M to support its going-private deal. https://seekingalpha.com/news/738341?source=tweet\" data-url=\"https://seekingalpha.com/news/738341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738321\" data-ts=\"1356724210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLR\" target=\"_blank\">CLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Continental Resources (CLR -2.2%) shares slide on news the energy company&#39;s CFO, vice chairman...</a></h4>Continental Resources (<a href='https://seekingalpha.com/symbol/CLR' title='Continental Resources, Inc.'>CLR</a> <font color=\"red\">-2.2%</font>) shares slide on news the energy company's <a href=\"http://xml.10kwizard.com/filing_raw.php?repo=tenk&amp;ipage=8627974\" target=\"_blank\">CFO</a>, vice chairman (<a href=\"http://xml.10kwizard.com/filing_raw.php?repo=tenk&amp;ipage=8626091\" target=\"_blank\">I</a>, <a href=\"http://xml.10kwizard.com/filing_raw.php?repo=tenk&amp;ipage=8627858\" target=\"_blank\">II</a>) and a <a href=\"http://xml.10kwizard.com/filing_raw.php?repo=tenk&amp;ipage=8627861\" target=\"_blank\">senior VP</a> sold a total of 69,498 shares at $72.46-$74.25 during the Dec. 21-27 period, worth a combined ~$5.1M.<div class=\"tiny-share-widget\" data-id=\"738321\" data-linked=\"Continental Resources (CLR -2.2%) shares slide on news the energy company&#39;s CFO, vice chairman...\" data-tweet=\"$CLR - Continental Resources (CLR -2.2%) shares slide on news the energy company&#39;s CFO, vice chairman (I, II) and a senior VP sold a total of 69,498 shares at $72.46-$74.25 during the Dec. 21-27 period, worth a combined ~$5.1M. https://seekingalpha.com/news/738321?source=tweet\" data-url=\"https://seekingalpha.com/news/738321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738291\" data-ts=\"1356722583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOQ\" target=\"_blank\">SOQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonde Resources (SOQ +14.3%) posts its second straight big gain after the Africa-focused energy...</a></h4><p>Sonde Resources (<a href=\"https://seekingalpha.com/symbol/SOQ\" title=\"Sonde Resources Corp.\">SOQ</a> <font color=\"green\">+14.3%</font>) posts its second straight big gain after the Africa-focused energy company said it had farmed out two-thirds of its interest in the Joint Oil Block to Viking Energy North Africa for $3M and other considerations. Shares jumped 10% y<a href=\"https://seekingalpha.com/currents/post/736681\" target=\"_blank\">esterday</a> on news SOQ's North African exploration obligations were extended.</p><div class=\"tiny-share-widget\" data-id=\"738291\" data-linked=\"Sonde Resources (SOQ +14.3%) posts its second straight big gain after the Africa-focused energy...\" data-tweet=\"$SOQ - Sonde Resources (SOQ +14.3%) posts its second straight big gain after the Africa-focused energy company said it had farmed out two-thirds of its interest in the Joint Oil Block to Viking Energy North Africa for $3M and other considerations. Share... https://seekingalpha.com/news/738291?source=tweet\" data-url=\"https://seekingalpha.com/news/738291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738271\" data-ts=\"1356721741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOS\" target=\"_blank\">KTOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kratos Defense &amp;amp; Security Solutions (KTOS -1.8%) says its Unmanned Systems Solutions...</a></h4><p>Kratos Defense &amp; Security Solutions (<a href=\"https://seekingalpha.com/symbol/KTOS\" title=\"Kratos Defense &amp; Security Solutions, Inc.\">KTOS</a> <font color=\"red\">-1.8%</font>) says its Unmanned Systems Solutions division has recently been awarded a contract totaling $4.6M to provide specialized equipment in support of a radar system program for an unnamed international customer. The equipment is being designed, engineered and produced in a secure manufacturing facility. No additional information is being provided due to security issues. </p><div class=\"tiny-share-widget\" data-id=\"738271\" data-linked=\"Kratos Defense &amp;amp; Security Solutions (KTOS -1.8%) says its Unmanned Systems Solutions...\" data-tweet=\"$KTOS - Kratos Defense &amp; Security Solutions (KTOS -1.8%) says its Unmanned Systems Solutions division has recently been awarded a contract totaling $4.6M to provide specialized equipment in support of a radar system program for an unnamed international ... https://seekingalpha.com/news/738271?source=tweet\" data-url=\"https://seekingalpha.com/news/738271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738261\" data-ts=\"1356721560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXC\" target=\"_blank\">MXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738261\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thinly traded Mexco Energy (MXC +11.8%) spikes higher after confirming acquisition of...</a></h4><p>Thinly traded Mexco Energy (<a href=\"https://seekingalpha.com/symbol/MXC\" title=\"Mexco Energy Corporation\">MXC</a> <font color=\"green\">+11.8%</font>) spikes higher after confirming acquisition of non-operated working interests in more than 200 wells producing primarily oil. MXC says the cash purchase price of $1.15M was funded from its $4.9M bank credit facility.</p><div class=\"tiny-share-widget\" data-id=\"738261\" data-linked=\"Thinly traded Mexco Energy (MXC +11.8%) spikes higher after confirming acquisition of...\" data-tweet=\"$MXC - Thinly traded Mexco Energy (MXC +11.8%) spikes higher after confirming acquisition of non-operated working interests in more than 200 wells producing primarily oil. MXC says the cash purchase price of $1.15M was funded from its $4.9M bank credit ... https://seekingalpha.com/news/738261?source=tweet\" data-url=\"https://seekingalpha.com/news/738261\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738211\" data-ts=\"1356719610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGYP\" target=\"_blank\">SGYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synergy Pharmaceuticals (SGYP -2.2%) slips after saying it has completed a Phase I clinical...</a></h4><p>Synergy Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/SGYP\" title=\"Synergy Pharmaceuticals, Inc.\">SGYP</a> <font color=\"red\">-2.2%</font>) slips after saying it has completed a Phase I clinical trials of SP-333, a treatment for ulcerative colitis and other GI diseases. According to the results, SP-333 exhibited potent anti-inflammatory activity in animal studies, which the company believes can provide a new way to treat UC patients with mild to moderate disease. The company plans to start a multi-dose escalation trial in January.</p><div class=\"tiny-share-widget\" data-id=\"738211\" data-linked=\"Synergy Pharmaceuticals (SGYP -2.2%) slips after saying it has completed a Phase I clinical...\" data-tweet=\"$SGYP $SGYP-OLD - Synergy Pharmaceuticals (SGYP -2.2%) slips after saying it has completed a Phase I clinical trials of SP-333, a treatment for ulcerative colitis and other GI diseases. According to the results, SP-333 exhibited potent anti-inflammatory... https://seekingalpha.com/news/738211?source=tweet\" data-url=\"https://seekingalpha.com/news/738211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738141\" data-ts=\"1356716742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIT\" target=\"_blank\">TRIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738141\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: TRIT +57%. AMPL +22%. AEZS +16%. LDK +13%. SOQ +13%. YONG +13%. PAMT...</a></h4><b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/TRIT\" title=\"Tri-Tech Holding, Inc.\">TRIT</a> <font color=\"green\">+57%</font>. <a href=\"https://seekingalpha.com/symbol/AMPL\" title=\"Ampal - American Israel Corporation\">AMPL</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/SOQ\" title=\"Sonde Resources Corp.\">SOQ</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/YONG\" title=\"Yongye International Inc\">YONG</a> <font color=\"green\">+13%</font>. PAMT <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/ABCD\" title=\"Cambium Learning Group, Inc.\">ABCD</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/MNOV\" title=\"MediciNova, Inc.\">MNOV</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/MNGA\" title=\"MagneGas Corporation\">MNGA</a> <font color=\"green\">+10%</font>. <br><b>Midday top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/ISSC\" title=\"Innovative Solutions and Support, Inc.\">ISSC</a> <font color=\"red\">-31%</font>. <a href=\"https://seekingalpha.com/symbol/BAGL\" title=\"Einstein Noah Restaurant Group, Inc.\">BAGL</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/FSGI\" title=\"First Security Group, Inc.\">FSGI</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/PLBC\" title=\"Plumas Bancorp\">PLBC</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/BOSC\" title=\"B.O.S. Better Online Solutions\">BOSC</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/OMER\" title=\"Omeros Corporation\">OMER</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/AMBO\" title=\"Ambow Education Holding Ltd.\">AMBO</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/MOC\" title=\"Command Security Corporation\">MOC</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SMED\" title=\"SHARPS COMPLIANCE CORP\">SMED</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/PRIS\" title=\"Promotora de Informaciones, S.A.\">PRIS</a> <font color=\"red\">-8%</font>.<div class=\"tiny-share-widget\" data-id=\"738141\" data-linked=\"Midday top 10 gainers: TRIT +57%. AMPL +22%. AEZS +16%. LDK +13%. SOQ +13%. YONG +13%. PAMT...\" data-tweet=\"$TRIT $TRIT $AMPL - Midday top 10 gainers: TRIT +57%. AMPL +22%. AEZS +16%. LDK +13%. SOQ +13%. YONG +13%. PAMT +11%. ABCD +11%. MNOV +10%. MNGA +10%. Midday top 10 Losers: ISSC -31%. BAGL -26%. FSGI -15%. PLBC -14%. BOSC -13%. OMER -11%. AMBO -9%. MOC ... https://seekingalpha.com/news/738141?source=tweet\" data-url=\"https://seekingalpha.com/news/738141\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"738121\" data-ts=\"1356715573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPHD\" target=\"_blank\">CPHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/738121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cepheid (CPHD +3.8%) moves up today after the company received FDA clearance for its Xpert CT/NG...</a></h4><p>Cepheid (<a href=\"https://seekingalpha.com/symbol/CPHD\" title=\"CEPHEID\">CPHD</a> <font color=\"green\">+3.8%</font>) moves up today after the company received FDA clearance for its Xpert CT/NG diagnostic test, for the rapid detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae.</p><div class=\"tiny-share-widget\" data-id=\"738121\" data-linked=\"Cepheid (CPHD +3.8%) moves up today after the company received FDA clearance for its Xpert CT/NG...\" data-tweet=\"$CPHD - Cepheid (CPHD +3.8%) moves up today after the company received FDA clearance for its Xpert CT/NG diagnostic test, for the rapid detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae. https://seekingalpha.com/news/738121?source=tweet\" data-url=\"https://seekingalpha.com/news/738121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737991\" data-ts=\"1356711423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LDK\" target=\"_blank\">LDK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks are rallying again, likely thanks to year-end short-covering (previous). LDK +9.2%....</a></h4><p>Solar stocks are rallying again, likely thanks to year-end short-covering (previous). <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"green\">+9.2%</font>. <a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a> <font color=\"green\">+6.8%</font>. <a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+3.6%</font>. GTAT <font color=\"green\">+4.6%</font>. <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"green\">+4.7%</font>.  MEMC (WFR <font color=\"green\">+3.2%</font>) is in the news: the company announced board members John Marren and William Stevens, each of whom have served for 11 years, are retiring (this should strengthen the hand of activist firm <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/582561\">Atlai Capital</a>), and that its SunEdison unit has sold 24MW of solar projects to Canadian Solar (<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+3.6%</font>).</p><div class=\"tiny-share-widget\" data-id=\"737991\" data-linked=\"Solar stocks are rallying again, likely thanks to year-end short-covering (previous). LDK +9.2%....\" data-tweet=\"$LDK $LDK $STP - Solar stocks are rallying again, likely thanks to year-end short-covering (previous). LDK +9.2%. STP +6.8%. CSIQ +3.6%. GTAT +4.6%. YGE +4.7%.  MEMC (WFR +3.2%) is in the news: the company announced board members John Marren and William... https://seekingalpha.com/news/737991?source=tweet\" data-url=\"https://seekingalpha.com/news/737991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737971\" data-ts=\"1356710736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Aeterna (NASDAQ:AEZS) are now soaring, up over 18% on the back of earlier reports that...</a></h4><p>Shares of Aeterna (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a>) are now soaring, up over <font color=\"green\">18%</font> on the back of <a href=\"https://seekingalpha.com/market_currents/post/737671\" target=\"_blank\">earlier reports</a> that it's reached an agreement with the FDA on a Special Protocol Assessment for Phase 3 trials of its endometrial cancer treatment doxorubicin eptide conjugate, or AEZS-108. The company says the agreement provides it with \"a clearly defined development and regulatory pathway.\"</p><div class=\"tiny-share-widget\" data-id=\"737971\" data-linked=\"Shares of Aeterna (NASDAQ:AEZS) are now soaring, up over 18% on the back of earlier reports that...\" data-tweet=\"$AEZS - Shares of Aeterna (NASDAQ:AEZS) are now soaring, up over 18% on the back of earlier reports that it&#39;s reached an agreement with the FDA on a Special Protocol Assessment for Phase 3 trials of its endometrial cancer treatment doxorubicin eptide co... https://seekingalpha.com/news/737971?source=tweet\" data-url=\"https://seekingalpha.com/news/737971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737941\" data-ts=\"1356710545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchronoss (SNCR +2.7%) trades higher following its $55.5M purchase of RIM&#39;s NewBay unit, which...</a></h4><p>Synchronoss (<a href=\"https://seekingalpha.com/symbol/SNCR\" title=\"Synchronoss Technologies, Inc.\">SNCR</a> <font color=\"green\">+2.7%</font>) trades higher following its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/737321\">$55.5M purchase</a> of RIM's NewBay unit, which provides private-label content tools and storage services for mobile carriers. <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/12/12/3203477/j-p-morgan-reiterates-overweight-rating-on-synchronoss-t\">JPMorgan</a> (Overweight) thinks NewBay's assets will complement Synchronoss' <a target=\"_blank\" href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=197199&amp;p=irol-newsArticle&amp;ID=1349747&amp;highlight\">ConvergenceNow</a> mobile activation/provisioning platform, and likes the fact the purchase expands Synchronoss' international customer base - Synchronoss is currently very dependent on AT&amp;T and Verizon.</p><div class=\"tiny-share-widget\" data-id=\"737941\" data-linked=\"Synchronoss (SNCR +2.7%) trades higher following its $55.5M purchase of RIM&#39;s NewBay unit, which...\" data-tweet=\"$SNCR - Synchronoss (SNCR +2.7%) trades higher following its $55.5M purchase of RIM&#39;s NewBay unit, which provides private-label content tools and storage services for mobile carriers. JPMorgan (Overweight) thinks NewBay&#39;s assets will complement Synchron... https://seekingalpha.com/news/737941?source=tweet\" data-url=\"https://seekingalpha.com/news/737941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737911\" data-ts=\"1356709892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOWR\" target=\"_blank\">TOWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower International (TOWR +13.4%) jumps higher this morning after saying it&#39;s sold its Korean...</a></h4><p>Tower International (<a href=\"https://seekingalpha.com/symbol/TOWR\" title=\"Tower International, Inc.\">TOWR</a> <font color=\"green\">+13.4%</font>) jumps higher this morning after saying it's sold its Korean operations for an estimated $47M in cash. The company said the buyer will assume $98 million in net debt averaged over the last 12 months through November, putting the transaction enterprise value at approximately $145M, or 5.8 times projected 2012 adjusted earnings.</p><div class=\"tiny-share-widget\" data-id=\"737911\" data-linked=\"Tower International (TOWR +13.4%) jumps higher this morning after saying it&#39;s sold its Korean...\" data-tweet=\"$TOWR - Tower International (TOWR +13.4%) jumps higher this morning after saying it&#39;s sold its Korean operations for an estimated $47M in cash. The company said the buyer will assume $98 million in net debt averaged over the last 12 months through Novem... https://seekingalpha.com/news/737911?source=tweet\" data-url=\"https://seekingalpha.com/news/737911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737881\" data-ts=\"1356709047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIME\" target=\"_blank\">LIME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lime Energy (LIME -6.7%) says its internal review determined financial statements during 2008-09...</a></h4><p>Lime Energy (<a href=\"https://seekingalpha.com/symbol/LIME-OLD\" title=\"lime energy co.\">LIME</a> <font color=\"red\">-6.7%</font>) says its internal review determined financial statements during 2008-09 should no longer be relied upon, and the company cannot yet make a reliable estimate of the magnitude of misreported revenue or the effects on the 2008-09 statements.</p><div class=\"tiny-share-widget\" data-id=\"737881\" data-linked=\"Lime Energy (LIME -6.7%) says its internal review determined financial statements during 2008-09...\" data-tweet=\"$LIME $LIME-OLD - Lime Energy (LIME -6.7%) says its internal review determined financial statements during 2008-09 should no longer be relied upon, and the company cannot yet make a reliable estimate of the magnitude of misreported revenue or the effect... https://seekingalpha.com/news/737881?source=tweet\" data-url=\"https://seekingalpha.com/news/737881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737701\" data-ts=\"1356705159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Not found in the press release trumpeting the Pearson investment in Nook Media, the related 8-K...</a></h4><p>Not found in the press release trumpeting <a href=\"https://seekingalpha.com/currents/post/737621\" target=\"_blank\">the Pearson investment</a> in Nook Media, the related <a href=\"http://forinvestors.barnesandnobleinc.com/secfiling.cfm?filingID=950157-12-592\" target=\"_blank\">8-K</a> says Barnes &amp; Noble (NYSE:<a href=\"https://seekingalpha.com/symbol/BKS\" title=\"Barnes &amp; Noble Inc\">BKS</a>) expects holiday sales results will be below expectations and that the Nook business \"will not meet the company's prior projection for FY 2013.\" Shares come off the premarket highs, now <font color=\"green\">+2.5%</font>.</p><div class=\"tiny-share-widget\" data-id=\"737701\" data-linked=\"Not found in the press release trumpeting the Pearson investment in Nook Media, the related 8-K...\" data-tweet=\"$BKS - Not found in the press release trumpeting the Pearson investment in Nook Media, the related 8-K says Barnes &amp; Noble (NYSE:BKS) expects holiday sales results will be below expectations and that the Nook business &quot;will not meet the company&#39;s prior ... https://seekingalpha.com/news/737701?source=tweet\" data-url=\"https://seekingalpha.com/news/737701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737671\" data-ts=\"1356704839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AEterna Zentaris (NASDAQ:AEZS) +4.8% premarket after announcing the FDA supports a phase 3 trial...</a></h4><p>AEterna Zentaris (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a>) <font color=\"green\">+4.8%</font> premarket after announcing the FDA supports a phase 3 trial of its drug AEZS-108, a potential treatment for endometrial cancer. A \"special protocol assessment\" agreement says the proposed trial protocol design, clinical  endpoints and planned analyses are acceptable to the FDA to support a  regulatory submission.</p><div class=\"tiny-share-widget\" data-id=\"737671\" data-linked=\"AEterna Zentaris (NASDAQ:AEZS) +4.8% premarket after announcing the FDA supports a phase 3 trial...\" data-tweet=\"$AEZS - AEterna Zentaris (NASDAQ:AEZS) +4.8% premarket after announcing the FDA supports a phase 3 trial of its drug AEZS-108, a potential treatment for endometrial cancer. A &quot;special protocol assessment&quot; agreement says the proposed trial protocol desig... https://seekingalpha.com/news/737671?source=tweet\" data-url=\"https://seekingalpha.com/news/737671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737641\" data-ts=\"1356703805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: AEZS +5%.</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a> <font color=\"green\">+5%</font>.<div class=\"tiny-share-widget\" data-id=\"737641\" data-linked=\"Premarket gainers: AEZS +5%.\" data-tweet=\"$AEZS - Premarket gainers: AEZS +5%. https://seekingalpha.com/news/737641?source=tweet\" data-url=\"https://seekingalpha.com/news/737641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737621\" data-ts=\"1356703456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes&amp;nbsp;&amp;amp;&amp;nbsp;Noble (NYSE:BKS) +8% premarket after Pearson (NYSE:PSO) says it will...</a></h4><p>Barnes &amp; Noble (NYSE:<a href=\"https://seekingalpha.com/symbol/BKS\" title=\"Barnes &amp; Noble Inc\">BKS</a>) <font color=\"green\">+8%</font> premarket after Pearson (NYSE:<a href=\"https://seekingalpha.com/symbol/PSO\" title=\"Pearson plc\">PSO</a>) says it will invest $89.5M in Nook Media in exchange for a 5% equity stake. BKS says the strategic investment \"will accelerate customer access to digital content by pairing [Pearson's] leading expertise in online learning with Nook Media's expertise in online distribution.\" Following the transaction, BKS will own 78.2% of Nook: Microsoft will own 16.6%.</p><div class=\"tiny-share-widget\" data-id=\"737621\" data-linked=\"Barnes &amp;amp; Noble (NYSE:BKS) +8% premarket after Pearson (NYSE:PSO) says it will invest $89.5M...\" data-tweet=\"$BKS $BKS $PSO - Barnes &amp; Noble (NYSE:BKS) +8% premarket after Pearson (NYSE:PSO) says it will invest $89.5M in Nook Media in exchange for a 5% equity stake. BKS says the strategic investment &quot;will accelerate customer access to digital content by pairin... https://seekingalpha.com/news/737621?source=tweet\" data-url=\"https://seekingalpha.com/news/737621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737591\" data-ts=\"1356702401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHRCQ\" target=\"_blank\">MHRCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magnum Hunter Resources (MHR) +2.4% premarket after announcing &quot;significant&quot; production results...</a></h4><p>Magnum Hunter Resources (MHR) <font color=\"green\">+2.4%</font> premarket after announcing \"significant\" production results from two new company-operated Eagle Ford Shale wells. Rhino Hunter #1 is producing ~2,033 bbl/day of oil and 1,113 mcf of natural gas, and Zebra Hunter #1 is producing ~1,995 bbl/day of oil and 898 mcf of natural gas.</p><div class=\"tiny-share-widget\" data-id=\"737591\" data-linked=\"Magnum Hunter Resources (MHR) +2.4% premarket after announcing &quot;significant&quot; production results...\" data-tweet=\"$MHRCQ - Magnum Hunter Resources (MHR) +2.4% premarket after announcing &quot;significant&quot; production results from two new company-operated Eagle Ford Shale wells. Rhino Hunter #1 is producing ~2,033 bbl/day of oil and 1,113 mcf of natural gas, and Zebra Hun... https://seekingalpha.com/news/737591?source=tweet\" data-url=\"https://seekingalpha.com/news/737591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737581\" data-ts=\"1356702122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instagram (NASDAQ:FB) may have already lost about 25% of its users after last week&#39;s uproar over...</a></h4><p>Instagram (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a>) may have <a href=\"http://www.cnbc.com/id/100343045\" target=\"_blank\">already lost about 25%</a> of its users after <a href=\"https://seekingalpha.com/currents/post/725821\" target=\"_blank\">last week's uproar </a>over changes to its policies, reports the <em>New York Post</em>, quoting figures from AppData. The metrics firm pegs Instagram's active daily users at 12.4M, down from 16.4M. FB <font color=\"red\">-1.4%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"737581\" data-linked=\"Instagram (NASDAQ:FB) may have already lost about 25% of its users after last week&#39;s uproar over...\" data-tweet=\"$FB - Instagram (NASDAQ:FB) may have already lost about 25% of its users after last week&#39;s uproar over changes to its policies, reports the New York Post, quoting figures from AppData. The metrics firm pegs Instagram&#39;s active daily users at 12.4M, down ... https://seekingalpha.com/news/737581?source=tweet\" data-url=\"https://seekingalpha.com/news/737581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"737551\" data-ts=\"1356701316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALL\" target=\"_blank\">CALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/737551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagicJack VocalTec (NASDAQ:CALL) +7.5% premarket after raising its outlook for Q4 and full-year...</a></h4><p>MagicJack VocalTec (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CALL\" title=\"magicJack VocalTec Communications Ltd.\">CALL</a>) <font color=\"green\">+7.5%</font> premarket after raising its outlook for Q4 and full-year 2012. For Q4, CALL expects more than $0.70/share of operating income, and has reduced share count by ~500K and increased cash by $6M since Q3. Also appoints Gerald Vento as President and CEO effective Jan. 1; founder Daniel Borislow will lead new marketing and product development initiatives.</p><div class=\"tiny-share-widget\" data-id=\"737551\" data-linked=\"MagicJack VocalTec (NASDAQ:CALL) +7.5% premarket after raising its outlook for Q4 and full-year...\" data-tweet=\"$CALL - MagicJack VocalTec (NASDAQ:CALL) +7.5% premarket after raising its outlook for Q4 and full-year 2012. For Q4, CALL expects more than $0.70/share of operating income, and has reduced share count by ~500K and increased cash by $6M since Q3. Also a... https://seekingalpha.com/news/737551?source=tweet\" data-url=\"https://seekingalpha.com/news/737551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li>","count":23,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}